The FDA on Thursday awarded six new Commissioner’s National Priority Vouchers for a variety of conditions including lung cancer, rectal cancer and weight loss.

Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. The US is the largest market globally for pharmaceutical sales, so ...

FDA Policy Changes Could Bring Some Biosimilars To Market Faster. Legal News and Analysis - USA - Intellectual Property - Conventus Law ...

ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers ...

Co-founded by former Bloomberg fintech executive Leslie Tang, makeup artist Wing Sze Tang and illustrator Gracie Tullio, ...

Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth ...

Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Knight defined adjusted EBITDA as operating income or loss, excluding amortization and impairment of noncurrent assets, depreciation, the impact of accounting under hyperinflation, acquisition costs ...